Are You At Risk?

We know you don’t want to worry about getting sick while traveling. Even if you follow every precaution, ticks can sneak up on you. According to the World Health Organization, vaccination is considered the most effective prevention measure for TBE.1
There are a range of travel risk factors that may increase your chance of TBE infection.2 Taking a moment to understand the risks can be the difference between coming home with memories to last a lifetime or a rare, but serious infection.
Our travel risk factors questionnaire is here to help. Click on the applicable questions about your travel plans below, and we’ll let you know if you’re at increased risk of TBE.

TAKE THE QUIZ

question1_icon
Question 1
Do you plan to visit Europe or Asia in the next 12 months?
LEARN MORE
question1_icon
Ticks infected with the TBE virus are not confined to one country but have been reported from Europe to Asia.2,3 TBE has been reported in over 30 countries,* and is crossing geographic boundaries into new areas.2,3
You may be at risk if you plan to travel to one of the countries highlighted.
question2_icon
Question 2
Do you plan to travel from April through November?
LEARN MORE
question2_icon
Risk level for exposure to infected ticks can change throughout the calendar year, based on when ticks are most active.2 Ticks are typically most active from April through November.2
question3_icon
Question 3
Do you plan to spend time outdoors?
LEARN MORE
question3_icon

Ticks live outdoors and near the ground.2 Where you spend your time can increase the likelihood of being bitten by an infected tick.2,3

Ticks are found most often in wooded or grassy areas, in parks, gardens, and forests.4 Simply walking in the forested park can put you at risk in some countries.4​​​​​​​

question4_icon
Question 4
Will you spend time camping, playing golf, gardening, hiking/ walking, visiting a park?
LEARN MORE
question4_icon
Outdoor activities can put you at risk of coming into contact with ticks.2,3 You may be at risk based on activities that mainly take place in grassy areas where ticks are commonly found.2,3
If you answered YES to any of the travel questions above, you may be at increased risk of TBE.
Don’t worry, you can still enjoy your vacation. Learn how to take precautions and help protect yourself from tick bites and TBE. Then talk to your doctor about the importance of vaccination for yourself and your loved ones.
LEARN HOW TO HELP PROTECT YOURSELF
* Albania, Austria, Belarus, Bosnia and Herzegovina, China, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Japan, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Mongolia, Netherlands, Norway, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, South Korea, Sweden, Switzerland, Ukraine.2,3
References
  1. World Health Organization Regional Office for Europe & European Center for Disease Prevention and Control. Tick-borne encephalitis in Europe. Accessed February 24, 2022. https://www.euro.who.int/en/about-us/whd/past-themes-of-world-health-day/2014-vector-borne-diseases/fact-sheets-world-health-day-2014-vector-borne-diseases/fact-sheet-tick-borne-encephalitis-in-europe.
  2. Fischer M, Gould CV, Rollin PE. Tickborne Encephalitis. Centers for Disease Control and Prevention. CDC Yellow Book 2020: Health Information for International Travel. New York: Oxford University Press;2017. Chap 4. Accessed February 24, 2022. https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/tickborne-encephalitis.
  3. Dobler G, Erber W, Bröker M, Schmitt HJ, eds. The TBE Book. 4th ed. Global Health Press; 2021.
  4. Travel Health Pro. Diseases in Brief. Tick-borne encephalitis. Accessed February 24, 2022. https://travelhealthpro.org.uk/disease/173/tick-borne-encephalitis.

IMPORTANT SAFETY INFORMATION AND INDICATION

Important Safety Information
  • TicoVac™ should not be given to anyone with a history of a severe allergic reaction after a previous dose of TicoVac™. 
  • TicoVac™ may not protect all individuals against TBE.
  • Some individuals with weakened immune systems may have a reduced immune response.
  • TicoVac™ contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases.
  • The most common adverse reactions in subjects 1 through 15 years of age who received TicoVac™ were local tenderness, local pain, headache, fever, and restlessness.
  • The most common adverse reactions in subjects 16 through 65 years of age who received TicoVac™ were local tenderness, local pain, fatigue, headache, and muscle pain.
  • Tell your healthcare provider if you are pregnant, or plan to become pregnant.
  • Ask your healthcare provider about the risks and benefits for TicoVac™. Only a healthcare provider can decide if TicoVac™ is right for you.
Indication

TicoVac™ is a vaccine indicated for active immunization to prevent tick-borne encephalitis (TBE) and is approved for use in individuals 1 year of age and older.

You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.

IMPORTANT SAFETY INFORMATION AND INDICATION

Important Safety Information
  • TicoVac™ should not be given to anyone with a history of a severe allergic reaction after a previous dose of TicoVac™. 
  • TicoVac™ may not protect all individuals against TBE.
  • Some individuals with weakened immune systems may have a reduced immune response.
  • TicoVac™ contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases.
  • The most common adverse reactions in subjects 1 through 15 years of age who received TicoVac™ were local tenderness, local pain, headache, fever, and restlessness.
  • The most common adverse reactions in subjects 16 through 65 years of age who received TicoVac™ were local tenderness, local pain, fatigue, headache, and muscle pain.
  • Tell your healthcare provider if you are pregnant, or plan to become pregnant.
  • Ask your healthcare provider about the risks and benefits for TicoVac™. Only a healthcare provider can decide if TicoVac™ is right for you.
Indication

TicoVac™ is a vaccine indicated for active immunization to prevent tick-borne encephalitis (TBE) and is approved for use in individuals 1 year of age and older.

You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.

Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.

This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries.

The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.

  • © 2022 Pfizer Inc.
  • All rights reserved.
  • Pfizer Inc. PO Box 29387, Mission, KS 66201
  • May 2022
  • PP-TCV-USA-0043
  • PP-TCV-USA-0043
  • PP-TCV-USA-0043